Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 6.61 Billion | USD 13.54 Billion | 8.3% | 2023 |
The global Bioresorbable Implants market size accrued earnings worth approximately USD 6.61 Billion in 2023 and is predicted to gain revenue of about USD 13.54 Billion by 2032, is set to record a CAGR of nearly 8.3% over the period from 2024 to 2032.
The study includes the drivers and restraints of the bioresorbable implants market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the bioresorbable implants market on a global level.
A medical implant that is made up of a material that can be absorbed by the body is known as a bioresorbable implant. These implants disintegrate with the change in time; in other words, there is a direct relationship between the implant’s disintegration and time, and its stresses are transferred into healing tissues. It provides temporary support to the body to heal the damaged tissues, post which it disappears. The implant’s actual benefit is that the tissues get temporary help to perform their original task.
Bioresorbable implants are used in numerous orthopedic, dental, and cardiovascular surgeries, which is the primary growth driver of the bioresorbable implants market globally. Furthermore, the high incidence of cardiovascular disease globally is anticipated to propel the demand for bioresorbable implants for cardiovascular surgeries, which, in turn, is predicted to boost the global bioresorbable implants market development over the forecast time period. Moreover, the increasing incidences of skeletal injuries are also likely to boost the bioresorbable implants market globally in the future. According to the WHO (World Health Organization), in 2018, road accidents caused between 20 and 50 million injuries annually around the world.
Moreover, in road crashes, about 1.25 million people die every year, i.e., an average of 3,287 deaths per day. Road traffic injuries are the foremost cause of death among people aged between 5 and 29 years. Additionally, the growing competition among the key players operating in the bioresorbable implants market for the development of innovative solutions is further anticipated to propel this market’s growth in the future.
In order to give the users of this report a comprehensive view of the bioresorbable implants market, we have included a competitive landscape and an analysis of Porter's Five Forces Model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers the product portfolio of various companies according to regions.
The global bioresorbable implants market is categorized into type, application, and end-user.
On the basis of type, the bioresorbable implants market includes metallic and polymer. The polymer segment is further divided into PLLA- Poly L-lactide, PLGA- Poly lactic-co-glycolic acid, PLA- Polylactic Acid, PGA- Polyglycolic Acid, and others.
By application, the global bioresorbable implants market is fragmented into orthopedic, cardiovascular, and others.
On the basis of end-user, the global bioresorbable implants market includes hospitals, ambulatory surgical centers, and others.
Report Attributes | Report Details |
---|---|
Report Name | Bioresorbable Implants Market |
Market Size in 2023 | USD 6.61 Billion |
Market Forecast in 2032 | USD 13.54 Billion |
Growth Rate | CAGR of 8.3% |
Number of Pages | 208 |
Key Companies Covered | Bioretec, CONMED Corporation, DePuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Smith & Nephew, and Boston Scientific Corporation |
Segments Covered | By type, By application, By end-user and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
By geography, North America accounted for the largest share of the global market in 2018 and is anticipated to remain the leading region over the forecast time period as well. The Asia Pacific region is expected to register the highest rate of growth in the global bioresorbable implants market in the future.
Some major players of the global bioresorbable implants market
Global Bioresorbable Implants Market: Type Analysis
Global Bioresorbable Implants Market: Application Analysis
Global Bioresorbable Implants Market: End-User Analysis
Global Bioresorbable Implants Market: Regional Analysis
FrequentlyAsked Questions
Bioresorbable implants are medical devices that are intended to temporarily fulfill their intended function and subsequently dissolve or be assimilated by the body over time. These implants are composed of biocompatible materials that can be safely degraded into non-toxic substances by the body's metabolic processes, thereby eliminating the necessity for surgical removal.
Bioresorbable implants offer a promising alternative to permanent implants, which are associated with complications such as the necessity for removal, as minimally invasive operations become more prevalent.
The global Bioresorbable Implants market size accrued earnings worth approximately USD 6.61 Billion in 2023 and is predicted to gain revenue of about USD 13.54 Billion by 2032.
The global Bioresorbable Implants market is set to record a CAGR of nearly 8.3% over the period from 2024 to 2032.
By geography, North America accounted for the largest share of the global market in 2018 and is anticipated to remain the leading region over the forecast time period as well. The Asia Pacific region is expected to register the highest rate of growth in the global bioresorbable implants market in the future.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed